Bridgebio Pharma Inc. – Investors and Politicians Who Own It

BBIO, 5 share classes and securities

Investors who own it

11 tracked investors, $1.6B in shares, each from their latest 13F.

InvestorValueShare of portfolio
$800.1M3.69%
Andreas HalvorsenViking Global Investors, Q2 2026
$741M2.11%
Ray DalioBridgewater Associates, Q2 2026
$33.4M0.14%
Daniel SchneebergerADAR1 Capital Management, Q2 2026
$13.2M0.60%
Daniel SchneebergerBondADAR1 Capital Management, Q2 2026
$5M0.23%
Daniel SchneebergerBondADAR1 Capital Management, Q2 2026
$4.9M0.23%
Daniel SchneebergerBondADAR1 Capital Management, Q2 2026
$3.5M0.16%
Mario GabelliBondGAMCO Investors, Q2 2026
$536K0.00%
$298.1K0.00%
Barry RitholtzRitholtz Wealth Management, Q2 2026
$289.3K0.00%
Barry RitholtzCallRitholtz Wealth Management, Q2 2026
$22.3K0.00%

Politicians who own it

Estimated from annual disclosures and trades; values are rough estimates.

PoliticianEst. valueShare of portfolio
$67.4K0.16%
InvestorActionShares now
Farallon Capital ManagementNew1,747,000
Joseph EdelmanSold out0
Zhang LeiReduced −26%1,023,950
Daniel SchneebergerAdded +15%1,448,470
Howard MarksBondReduced −61%1,246,000
Howard MarksBondReduced −38%2,382,000
Daniel SchneebergerCallSold out0
Daniel SchneebergerPutSold out0

Politicians trading it

Latest Congress trades disclosed under the STOCK Act; amounts are ranges.

PoliticianActionTraded
Bought$1K–$15KMay 11, 2026disclosed Jun 8, 2026
Bought$1K–$15KApr 29, 2026disclosed May 8, 2026
Bought$1K–$15KMar 19, 2026disclosed Apr 7, 2026
Bought$1K–$15KMar 18, 2026disclosed Apr 7, 2026
Bought$1K–$15KMar 3, 2026disclosed Apr 7, 2026
Bought$1K–$15KSep 22, 2025disclosed Oct 10, 2025
Bought$1K–$15KAug 8, 2025disclosed Sep 12, 2025